Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer – Newswise (press release)
|
Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer
Newswise (press release) A drug whose clinical testing was led by Charles S. Fuchs, MD, MPH, director of Yale Cancer Center, has become the first immunotherapy treatment for advanced stomach cancer. The drug, pembrolizumab (Keytruda®), was approved by the U.S. Food and … |
